Abbott Laboratories Shares Outstanding 2012-2025 | ABT

Abbott Laboratories shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Abbott Laboratories shares outstanding for the quarter ending December 31, 2025 were 1.747B, a 0.06% decline year-over-year.
  • Abbott Laboratories 2025 shares outstanding were 1.749B, a 0.06% increase from 2024.
  • Abbott Laboratories 2024 shares outstanding were 1.748B, a 0.06% decline from 2023.
  • Abbott Laboratories 2023 shares outstanding were 1.749B, a 0.85% decline from 2022.
Abbott Laboratories Annual Shares Outstanding
(Millions of Shares)
2025 1,749
2024 1,748
2023 1,749
2022 1,764
2021 1,789
2020 1,786
2019 1,781
2018 1,770
2017 1,749
2016 1,483
2015 1,506
2014 1,527
2013 1,574
2012 1,592
2011 1,567
Abbott Laboratories Quarterly Shares Outstanding
(Millions of Shares)
2025-12-31 1,747
2025-09-30 1,749
2025-06-30 1,751
2025-03-31 1,747
2024-12-31 1,748
2024-09-30 1,748
2024-06-30 1,751
2024-03-31 1,750
2023-12-31 1,749
2023-09-30 1,748
2023-06-30 1,750
2023-03-31 1,752
2022-12-31 1,764
2022-09-30 1,764
2022-06-30 1,765
2022-03-31 1,775
2021-12-31 1,789
2021-09-30 1,789
2021-06-30 1,793
2021-03-31 1,792
2020-12-31 1,786
2020-09-30 1,788
2020-06-30 1,785
2020-03-31 1,781
2019-12-31 1,781
2019-09-30 1,784
2019-06-30 1,781
2019-03-31 1,777
2018-12-31 1,770
2018-09-30 1,772
2018-06-30 1,769
2018-03-31 1,765
2017-12-31 1,749
2017-09-30 1,754
2017-06-30 1,749
2017-03-31 1,735
2016-12-31 1,483
2016-09-30 1,476
2016-06-30 1,480
2016-03-31 1,484
2015-12-31 1,506
2015-09-30 1,505
2015-06-30 1,504
2015-03-31 1,516
2014-12-31 1,527
2014-09-30 1,520
2014-06-30 1,517
2014-03-31 1,548
2013-12-31 1,574
2013-09-30 1,567
2013-06-30 1,577
2013-03-31 1,586
2012-12-31 1,592
2012-09-30 1,594
2012-06-30 1,589
2012-03-31 1,590
2011-12-31 1,577
2011-09-30 1,568
2011-06-30 1,566
2011-03-31 1,559
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $186.790B $44.328B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
EssilorLuxottica (ESLOY) France $145.149B 0.00
Boston Scientific (BSX) United States $137.141B 31.36
Stryker (SYK) United States $135.776B 26.96
Medtronic (MDT) Ireland $129.330B 17.92
Medline (MDLN) United States $60.431B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.968B 0.00
Agilent Technologies (A) United States $38.287B 24.20
ResMed (RMD) United States $36.833B 25.49
GE HealthCare Technologies (GEHC) United States $36.337B 17.38
Koninklijke Philips (PHG) Netherlands $28.310B 18.49
Terumo (TRUMY) Japan $20.239B 22.78
Insulet (PODD) United States $19.106B 59.30
Zimmer Biomet Holdings (ZBH) United States $17.163B 10.70
Smith & Nephew SNATS (SNN) United Kingdom $14.153B 0.00
Baxter (BAX) United States $10.199B 8.23
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $8.000B 28.77
Demant (WILYY) Denmark $7.372B 0.00
Lantheus Holdings (LNTH) United States $4.477B 13.64
BillionToOne (BLLN) United States $4.008B 0.00
Envista Holdings (NVST) United States $3.920B 22.49
ICU Medical (ICUI) United States $3.769B 23.93
Haemonetics (HAE) United States $3.221B 14.34
Prestige Consumer Healthcare (PBH) United States $3.164B 14.43
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
Neogen (NEOG) United States $2.132B 46.67
Perrigo (PRGO) Ireland $2.026B 5.08
AtriCure (ATRC) United States $1.942B 0.00
LeMaitre Vascular (LMAT) United States $1.911B 38.46
QuidelOrtho (QDEL) United States $1.908B 12.27
Curaleaf Holdings (CURLF) Canada $1.839B 0.00
Green Thumb Industries (GTBIF) United States $1.672B 73.27
Phibro Animal Health (PAHC) United States $1.581B 15.79
Kestra Medical Technologies (KMTS) United States $1.435B 0.00
AdaptHealth (AHCO) United States $1.366B 19.78
Lumexa Imaging Holdings (LMRI) United States $1.362B 0.00
BioLife Solutions (BLFS) United States $1.197B 355.29
Capricor Therapeutics (CAPR) United States $1.061B 0.00
Tilray Brands (TLRY) Canada $1.054B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.949B 0.00
InMode (INMD) Israel $0.882B 9.96
Omeros (OMER) United States $0.846B 0.00
Valneva SE (VALN) France $0.841B 0.00
CeriBell (CBLL) United States $0.828B 0.00
VAREX IMAGING (VREX) United States $0.581B 15.74
Verano Holdings (VRNO) United States $0.519B 0.00
Cerus (CERS) United States $0.478B 0.00
Brainsway (BWAY) Israel $0.451B 76.80
Cresco Labs (CRLBF) United States $0.447B 0.00
Canopy Growth (CGC) Canada $0.438B 0.00
Evolus (EOLS) United States $0.319B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Quanterix (QTRX) United States $0.303B 0.00
Viemed Healthcare (VMD) United States $0.278B 22.18
TriSalus Life Sciences (TLSI) United States $0.272B 0.00
Aurora Cannabis (ACB) Canada $0.251B 147.67
TerrAscend (TSNDF) Canada $0.243B 0.00
Sanuwave Health (SNWV) United States $0.228B 0.00
Organigram Global (OGI) Canada $0.224B 0.00
High Tide (HITI) Canada $0.223B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Utah Medical Products (UTMD) United States $0.196B 17.30
Sanara MedTech (SMTI) United States $0.194B 0.00
OraSure Technologies (OSUR) United States $0.192B 0.00
Vireo Growth (VREOF) United States $0.182B 0.00
Accendra Health (ACH) United States $0.163B 1.64
Quipt Home Medical (QIPT) United States $0.158B 0.00
Apyx Medical (APYX) United States $0.152B 0.00
FitLife Brands (FTLF) United States $0.148B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.135B 0.00
Jushi Holdings (JUSHF) United States $0.118B 0.00
Fonar (FONR) United States $0.115B 16.77
MacroGenics (MGNX) United States $0.114B 0.00
Exagen (XGN) United States $0.104B 0.00
Biote (BTMD) United States $0.101B 4.42
Sharps Technology (STSS) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.057B 24.08
Nephros (NEPH) United States $0.050B 36.00
Rockwell Medical (RMTI) United States $0.045B 0.00
Veru (VERU) United States $0.045B 0.00
Cytosorbents (CTSO) United States $0.043B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Bonk (BNKK) United States $0.032B 0.00
United-Guardian (UG) United States $0.030B 15.10
Jin Medical (ZJYL) China $0.021B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
INLIF (INLF) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Flora Growth (FLGC) United States $0.007B 0.00
Agape ATP (ATPC) $0.004B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00